Repligen (RGEN) Current Deferred Revenue (2011 - 2026)
Repligen (RGEN) posted quarterly Current Deferred Revenue of $19.6 million for Q2 2026, down 5.81% year-over-year from $20.8 million in Q2 2025, and up 7.05% quarter-over-quarter from $18.3 million in Q1 2026.
Repligen (RGEN) Current Deferred Revenue (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Current Deferred Revenue for 15 consecutive years, with $19.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Deferred Revenue fell 5.81% year-over-year to $19.6 million; the TTM figure through Jun 2026 stood at $19.6 million (down 5.81% YoY), while the FY2025 annual figure was $14.6 million, up 10.31% from the prior year.
- Current Deferred Revenue rose to $19.6 million in Q2 2026 per RGEN's latest filing, from $18.3 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $31.6 million in Q2 2023 and bottomed at $13.2 million in Q4 2024.
- Historically, Current Deferred Revenue has averaged $20.1 million across 5 years, with a median of $19.4 million in 2022.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue surged 54.95% — and 2024, when it sank 55.64%.
- Repligen's Current Deferred Revenue stood at $19.3 million in 2022, then slipped by 11.49% to $17.1 million in 2023, then fell by 22.41% to $13.2 million in 2024, then grew by 10.31% to $14.6 million in 2025, then jumped by 34.15% to $19.6 million in 2026.
- Business Quant data shows RGEN's Current Deferred Revenue at $19.6 million in Q2 2026, $18.3 million in Q1 2026, and $14.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.60 Mn |
| Mar 31, 2026 | 18.31 Mn |
| Dec 31, 2025 | 14.61 Mn |
| Sep 30, 2025 | 15.68 Mn |
| Jun 30, 2025 | 20.81 Mn |
| Mar 31, 2025 | 21.21 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Sep 30, 2024 | 16.45 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 19.21 Mn |
| Dec 31, 2023 | 17.07 Mn |
| Sep 30, 2023 | 27.95 Mn |
| Jun 30, 2023 | 31.56 Mn |
| Mar 31, 2023 | 31.11 Mn |
| Dec 31, 2022 | 19.28 Mn |
| Sep 30, 2022 | 19.47 Mn |
| Jun 30, 2022 | 22.16 Mn |
| Mar 31, 2022 | 20.08 Mn |
| Dec 31, 2021 | 14.68 Mn |
| Sep 30, 2021 | 16.34 Mn |